Related Experiment Video
Updated: May 10, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
The Ethics of Gene Therapy for Sickle Cell Disease
1Division of Medicine-Pediatrics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, USA.
Abstract:
Gene therapy for sickle cell disease (SCD) can drastically transform an individual's life and decrease the disease burden, but there are several ethical dilemmas associated with it. This editorial examines the various challenges, including the quality of informed consent, patient selection criteria, and equitable access. While gene therapy offers significant promise, addressing the ethical concerns surrounding it is crucial to ensure responsible implementation and equitable care for individuals with SCD and their communities.
Related Concept Videos
Gene Therapy
What is Genetic Engineering?
iPS Cell Differentiation
CRISPR
Multiple Allele Traits
Ethics and Bioethics

